148 related articles for article (PubMed ID: 1772965)
1. Repetitive exposure of pancreatic islets to interleukin-1 beta. An in vitro model of pre-diabetes?
Helqvist S; Zumsteg UW; Spinas GA; Palmer JP; Mandrup-Poulsen T; Egeberg J; Nerup J
Autoimmunity; 1991; 10(4):311-8. PubMed ID: 1772965
[TBL] [Abstract][Full Text] [Related]
2. Not all insulin secretagogues sensitize pancreatic islets to recombinant human interleukin 1 beta.
Johannesen J; Helqvist S; Nerup J
Acta Endocrinol (Copenh); 1990 Oct; 123(4):445-52. PubMed ID: 1700570
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
Sandler S; Bendtzen K; Eizirik DL; Welsh M
Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures.
Rabinovitch A; Pukel C; Baquerizo H
Endocrinology; 1988 Jun; 122(6):2393-8. PubMed ID: 2453340
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide partially reverses the interleukin-1 beta inhibition of glucose-induced insulin release in pancreatic islets.
Buscema M; Vinci C; Gatta C; Rabuazzo MA; Vignen R; Purrello F
Metabolism; 1992 Mar; 41(3):296-300. PubMed ID: 1531861
[TBL] [Abstract][Full Text] [Related]
8. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets.
Eizirik DL; Welsh N; Hellerström C
J Clin Endocrinol Metab; 1993 Feb; 76(2):399-403. PubMed ID: 8432782
[TBL] [Abstract][Full Text] [Related]
9. Human interleukin-1 beta induced stimulation of insulin release from rat pancreatic islets is accompanied by an increase in mitochondrial oxidative events.
Eizirik DL; Sandler S
Diabetologia; 1989 Nov; 32(11):769-73. PubMed ID: 2687062
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration.
Sandler S; Bendtzen K; Eizirik DL; Strandell E; Welsh M; Welsh N
Immunol Lett; 1990 Dec; 26(3):245-51. PubMed ID: 2086453
[TBL] [Abstract][Full Text] [Related]
11. Short-term exposure of rat pancreatic islets to human interleukin-1 beta increases cellular uptake of calcium.
Borg LA; Eizirik DL
Immunol Lett; 1990 Dec; 26(3):253-8. PubMed ID: 2086454
[TBL] [Abstract][Full Text] [Related]
12. Functional characteristics of rat pancreatic islets maintained in culture after exposure to human interleukin 1.
Eizirik DL; Strandell E; Bendtzen K; Sandler S
Diabetes; 1988 Jul; 37(7):916-9. PubMed ID: 3290009
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
[TBL] [Abstract][Full Text] [Related]
14. Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats.
Zumsteg U; Reimers JI; Pociot F; Mørch L; Helqvist S; Brendel M; Alejandro R; Mandrup-Poulsen T; Dinarello CA; Nerup J
Diabetologia; 1993 Aug; 36(8):759-66. PubMed ID: 8405744
[TBL] [Abstract][Full Text] [Related]
15. Different effects of glucose and glyburide on insulin secretion in rat pancreatic islets pre-exposed to interleukin-1 beta. Possible involvement of K+ and Ca2+ channels.
Buscema M; Rabuazzo AM; Vinci C; Caltabiano V; Vigneri R; Purrello F
Diabetologia; 1993 Sep; 36(9):791-6. PubMed ID: 8405748
[TBL] [Abstract][Full Text] [Related]
16. In vitro response to interleukin-1 beta and streptozotocin in pancreatic islets isolated from male and female nonobese diabetic mice.
Strandell E; Sandler S
J Endocrinol; 1997 Apr; 153(1):81-6. PubMed ID: 9135572
[TBL] [Abstract][Full Text] [Related]
17. Role of receptor binding and gene transcription for both the stimulatory and inhibitory effects of interleukin-1 in pancreatic beta-cells.
Eizirik DL; Tracey DE; Bendtzen K; Sandler S
Autoimmunity; 1992; 12(2):127-33. PubMed ID: 1535517
[TBL] [Abstract][Full Text] [Related]
18. Species differences in human and rat islet sensitivity to human cytokines. Monoclonal anti-interleukin-1 (IL-1) influences on direct and indirect IL-1-mediated islet effects.
Kawahara DJ; Kenney JS
Cytokine; 1991 Mar; 3(2):117-24. PubMed ID: 1888882
[TBL] [Abstract][Full Text] [Related]
19. Effects of cytokines on rat pancreatic islet cell monolayer cultures: distinction between functional and cytotoxic effects on islet beta-cells.
Rabinovitch A; Baquerizo H; Pukel C; Sumoski W
Reg Immunol; 1989; 2(2):77-82. PubMed ID: 2518361
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.
Rabuazzo AM; Buscema M; Caltabiano V; Anello M; Degano C; Patanè G; Vigneri R; Purrello F
Diabetologia; 1995 Jul; 38(7):779-84. PubMed ID: 7556978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
